National Health Investors, Inc. (NYSE:NHI) has earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $70.50.
A number of analysts have weighed in on NHI shares. BMO Capital Markets upgraded National Health Investors from an “underperform” rating to a “market perform” rating and set a $71.00 price target on the stock in a research report on Friday, June 18th. Zacks Investment Research lowered National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, June 23rd. Finally, Wells Fargo & Company reduced their price objective on National Health Investors from $74.00 to $72.00 and set an “equal weight” rating on the stock in a research note on Friday, July 23rd.
Shares of NYSE:NHI opened at $60.51 on Thursday. The business’s fifty day moving average price is $65.09 and its two-hundred day moving average price is $68.71. National Health Investors has a fifty-two week low of $53.70 and a fifty-two week high of $78.56. The stock has a market capitalization of $2.77 billion, a price-to-earnings ratio of 17.74 and a beta of 0.93. The company has a debt-to-equity ratio of 0.92, a current ratio of 16.11 and a quick ratio of 16.11.
National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Monday, August 9th. The real estate investment trust reported $0.85 earnings per share for the quarter, missing analysts’ consensus estimates of $1.25 by ($0.40). National Health Investors had a net margin of 48.09% and a return on equity of 10.04%. The company had revenue of $74.33 million during the quarter, compared to the consensus estimate of $77.22 million. During the same quarter last year, the company earned $1.46 earnings per share. The business’s revenue was down 11.7% on a year-over-year basis. Research analysts expect that National Health Investors will post 5.08 EPS for the current fiscal year.
When inflation hits an all time high, most investors see gold as a safe haven. However, this unusual investment is seeing 2:1 returns compared to gold. (While still giving you the protection that gold offers)
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 5th. Shareholders of record on Thursday, September 30th will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 5.95%. The ex-dividend date of this dividend is Wednesday, September 29th. National Health Investors’s dividend payout ratio is currently 64.29%.
In other news, Director Robert T. Webb purchased 1,184 shares of the business’s stock in a transaction dated Thursday, June 17th. The shares were acquired at an average price of $65.00 per share, with a total value of $76,960.00. Following the completion of the purchase, the director now directly owns 63,339 shares of the company’s stock, valued at approximately $4,117,035. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 6.55% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the company. Baldrige Asset Management LLC acquired a new position in shares of National Health Investors during the second quarter valued at $26,000. Edmond DE Rothschild Holding S.A. acquired a new position in shares of National Health Investors during the first quarter valued at $28,000. Marshall Wace North America L.P. acquired a new position in shares of National Health Investors during the first quarter valued at $31,000. Samalin Investment Counsel LLC acquired a new position in shares of National Health Investors during the second quarter valued at $36,000. Finally, FORA Capital LLC bought a new stake in National Health Investors in the first quarter valued at about $42,000. 58.57% of the stock is currently owned by institutional investors and hedge funds.
About National Health Investors
National Health Investors, Inc is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings.
See Also: Why do earnings reports matter?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and National Health Investors wasn’t on the list.
While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.